EUVIMEDEUVIMED entdecken
Crossref

Comprehensive Analysis of TEK Variants in Patients With Vascular Malformations

Reza Ghasemi, Meagan M Corliss, Kevin M Bowling, Kilannin Krysiak iD, Jason Walker, Alexa M Dickson, Molly C Schroeder, Bijal A Parikh, Julie A Neidich, Katarzyna Polonis, Yang Cao

Clinical Genetics · 2025

DOI: 10.1111/cge.14667 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Reza Ghasemi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Vascular Malformations, Receptor, TIE-2, Genetic Predisposition to Disease, Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic variants in the receptor tyrosine kinase TIE2, encoded by TEK , are known to cause vascular malformations (VMs). In this study, we retrospectively reviewed the deidentified data generated through clinical NGS testing in our laboratory and found 88 VM cases with a total of 107 clinically significant TEK variants. Among those, 23 unique variants at the amino acid level were identified, including five novel (p.Cys1040Arg, p.Arg1099PhefsTer12, p.Glu1109Ter, p.Phe1111LeufsTer7, p.Phe1111ValfsTer7) and 18 previously published variants. Missense variants were identified more often in the tyrosine kinase domain, while all nonsense/frameshift variants were clustered in the C‐terminal tail (CTT). In addition, most variants occurred as solitary alterations, whereas certain variants always co‐occurred with a second TEK variant. Five patterns of TEK variants (P1–P5) were identified: (P1) Arg849 + another variant; (P2) Tyr897 + another variant; (P3) Leu914 single variants; (P4) Arg915/918 single variants; and (P5) CTT single /co‐occurring variants. This study provides the most comprehensive view of pathogenic TEK variants in VMs to date.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular MalformationsReceptor, TIE-2Genetic Predisposition to DiseaseMutationHumansFemaleMaleChildHigh-Throughput Nucleotide SequencingRetrospective StudiesChild, PreschoolGenetic Association StudiesMutation, MissenseAdolescentAdultInfant

Stichwörter der Autor:innen

TEKNGSTIE2disorders of somatic mosaicismvascular malformations (VM)

Substanzen

Receptor, TIE-2

Autor:innen und Institutionen

  • Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.

ORCID-Profile: Kilannin Krysiak

Zitieren

APA

Ghasemi, R., Corliss, M. M., Bowling, K. M., Krysiak, K., Walker, J., Dickson, A. M., Schroeder, M. C., Parikh, B. A., Neidich, J. A., Polonis, K., & Cao, Y. (2025). Comprehensive Analysis of TEK Variants in Patients With Vascular Malformations. Clinical Genetics. https://doi.org/10.1111/cge.14667

Vancouver

Ghasemi R, Corliss MM, Bowling KM, Krysiak K, Walker J, Dickson AM, et al. Comprehensive Analysis of TEK Variants in Patients With Vascular Malformations. Clinical Genetics. 2025. doi:10.1111/cge.14667

BibTeX
@article{Ghasemi2025,
  author = {Ghasemi, Reza and Corliss, Meagan M and Bowling, Kevin M and Krysiak, Kilannin and Walker, Jason and Dickson, Alexa M and Schroeder, Molly C and Parikh, Bijal A and Neidich, Julie A and Polonis, Katarzyna and Cao, Yang},
  title = {Comprehensive Analysis of TEK Variants in Patients With Vascular Malformations},
  journal = {Clinical Genetics},
  year = {2025},
  doi = {10.1111/cge.14667}
}
Kostenlos starten →